遺伝子疾患研究のコストを低減する新型センサーを開発(New Sensors Lower the Cost of Studying Genetic Disorders)

ad

2026-04-02 ノースカロライナ州立大学(NCState))

米国のNorth Carolina State Universityの研究チームは、遺伝性疾患研究のコストを大幅に低減する新しいセンサー技術を開発した。従来の遺伝子解析は高価な装置や複雑な手法を必要としたが、本研究では低コストかつ簡便なセンサーを用いて、特定の遺伝子変異や分子反応を効率的に検出可能にした。これにより、研究のアクセス性が向上し、より多くの研究機関や臨床現場での活用が期待される。特に希少疾患や個別化医療の分野において、迅速かつ経済的な診断・研究手法として重要な意義を持つ。

<関連情報>

カーボンナノチューブマイクロ電極アレイにより、脳オルガノイドの拡張性とアクセス性に優れた電気生理学的記録が可能になる Carbon nanotube microelectrode arrays enable scalable and accessible electrophysiological recordings of cerebral organoids

Navya Mishra,Rajaram Kaveti,Pei Liu,Baha Erim Uzunoglu,Aram Mirabedini,Anna Tran,Z. Begum Yagci,Tyler Johnson,Parvez Ahmmed,Qiuli Wang,Jeong Yong Kim,Paris Brown,Surjendu Maity,Shyni Varghese,Michael D. Dickey,Yong Zhu,Alper Bozkurt,Raudel Avila,Albert J. Keung & Amay J. Bandodkar
npj Biosensing  Published:01 April 2026
DOI:https://doi.org/10.1038/s44328-026-00088-9

遺伝子疾患研究のコストを低減する新型センサーを開発(New Sensors Lower the Cost of Studying Genetic Disorders)

Abstract

Human cerebral organoids hold promise for studying neurodevelopment, modelling disease, and drug screening. Electrophysiology is a key functional property for these studies; yet, performing high-throughput electrophysiological studies with organoids remains a critical bottleneck. Current state-of-the-art recording technologies, including 2D and 3D microelectrode arrays (MEAs), are low-throughput, expensive to fabricate and purchase, and often incompatible with routine organoid culture. These limitations restrict their adoption, and many studies report electrophysiological activity from insufficient sample sizes to accurately capture the widely accepted biological variability inherent to organoid models. Here, we present a scalable, low-cost, plug-and-play platform that integrates a new class of carbon nanotube-based 3D microelectrode arrays into standard cell culture plates. This system enables high-throughput extracellular recordings from many organoids without specialised workflows. Using this system, we record electrophysiological signals from 74 human cortical organoids, the largest scale reported in organoid electrophysiology studies to the best of our knowledge. The measurements involve capturing electrophysiological phenotypes across neurotypical and Angelman Syndrome organoids. We also show that the use of carbon nanotubes in place of conventional gold electrodes achieves superior electrical, electrochemical, and electromechanical properties at a fraction of the cost while enabling a new scalable manufacturing technique. This technology establishes a standardised and accessible route to large-scale electrophysiological measurements in organoids.

細胞遺伝子工学
ad
ad
Follow
ad
タイトルとURLをコピーしました